Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01843751 · ClinicalTrials.gov registry record · Phase 3
Dane County Drug Court Study for Addicted Offenders
A Phase 3 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
NCT01843751 is a Phase 3 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 24 participants.
The verdict
NCT01843751, a Phase 3 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
Study Summary
The proposed work addresses critical health and public safety issues in the U.S. and in Wisconsin: the intersection of addiction and crime and the prevention of associated individual and public health complications. The results will provide justification for the expanded involvement of primary care in the treatment of substance-related disorders (opioid dependence in particular) and the prevention of their complications. As such, the project answers to federal calls for the expansion of substance abuse treatment into primary care settings and to objectives within the Alcohol and Drug Focus Area of Healthiest Wisconsin 2020.
Interventions
- DRUG buprenorphine/naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01843751
The ClinicalTrials.gov registry entry for NCT01843751 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which buprenorphine/naloxone is the first listed.
NCT01843751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01843751 about?
NCT01843751 is a clinical study titled "Dane County Drug Court Study for Addicted Offenders". The proposed work addresses critical health and public safety issues in the U.S. and in Wisconsin: the intersection of addiction and crime and the prevention of associated individual and public health complications. The results will provide justification for the expanded involvement of primary care ...
What is the current status of trial NCT01843751?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2013-03. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01843751?
The interventions under investigation include: buprenorphine/naloxone (DRUG).
Who is sponsoring clinical trial NCT01843751?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.